A new, error-corrected method for detecting cancer from blood samples is much more sensitive and accurate than prior methods and may be useful for monitoring disease status in patients following treatment, according to a study by Weill Cornell Medicine and New York Genome Center investigators. The method...
.png)
Market Touch Signal · Finland · international digital desk
+358 400 512311
info@market-touch.org
